NasdaqGM - Nasdaq Real Time Price USD

STAAR Surgical Company (STAA)

Compare
41.22 -0.69 (-1.65%)
At close: June 14 at 4:00 PM EDT
41.22 0.00 (0.00%)
After hours: June 14 at 4:58 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Thomas G. Frinzi President, CEO & Chairman 1.22M -- 1956
Mr. Patrick F. Williams Chief Financial Officer 746.92k -- 1973
Mr. Warren Foust Chief Operating Officer 666.81k -- 1976
Dr. Keith Holliday Ph.D. Chief Technology Officer 679.29k -- 1963
Dr. Scott D. Barnes M.D. Chief Medical Officer 691.15k -- 1963
Mr. Brian Moore Vice President of Investor Relations & Corporate Development -- -- --
Mr. Nathaniel B. Sisitsky Esq. General Counsel & Corporate Secretary -- -- 1974
Ms. Nancy Sabin Chief Marketing Officer -- -- --
Mr. James Francese Senior Vice President of Commercial Operations - North America & APAC 755.65k 882.3k 1964
Dr. Magda Michna Ph.D. Chief Clinical, Regulatory & Medical Affairs Officer -- -- --

STAAR Surgical Company

25651 Atlantic Ocean Drive
Lake Forest, CA 92630
United States
626 303 7902 https://www.staar.com
Sector: 
Healthcare
Full Time Employees: 
1,056

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Corporate Governance

STAAR Surgical Company’s ISS Governance QualityScore as of June 1, 2024 is 5. The pillar scores are Audit: 3; Board: 5; Shareholder Rights: 7; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 31, 2024 at 10:59 AM UTC - August 5, 2024 at 12:00 PM UTC

STAAR Surgical Company Earnings Date

Recent Events

June 12, 2024 at 12:00 PM UTC

at Goldman Sachs Global Healthcare Conference

June 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 7, 2024 at 8:15 PM UTC

Q1 2024 Earnings Call

May 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 24, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

April 4, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 18, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 28, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 27, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers